Cargando…

First experience of effectiveness and safety of bedaquiline for 18 months within an optimised regimen for XDR-TB

The first successful use of bedaquiline for 18 months for XDR-TB as part of an optimised background regimen http://ow.ly/XE34x

Detalles Bibliográficos
Autores principales: Lewis, Joseph M., Hine, Paul, Walker, Jenny, Khoo, Saye H., Taegtmeyer, Miriam, Squire, S. Bertel, Sloan, Derek J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5394548/
https://www.ncbi.nlm.nih.gov/pubmed/26917618
http://dx.doi.org/10.1183/13993003.01980-2015
_version_ 1783229750455566336
author Lewis, Joseph M.
Hine, Paul
Walker, Jenny
Khoo, Saye H.
Taegtmeyer, Miriam
Squire, S. Bertel
Sloan, Derek J.
author_facet Lewis, Joseph M.
Hine, Paul
Walker, Jenny
Khoo, Saye H.
Taegtmeyer, Miriam
Squire, S. Bertel
Sloan, Derek J.
author_sort Lewis, Joseph M.
collection PubMed
description The first successful use of bedaquiline for 18 months for XDR-TB as part of an optimised background regimen http://ow.ly/XE34x
format Online
Article
Text
id pubmed-5394548
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher European Respiratory Society
record_format MEDLINE/PubMed
spelling pubmed-53945482017-04-21 First experience of effectiveness and safety of bedaquiline for 18 months within an optimised regimen for XDR-TB Lewis, Joseph M. Hine, Paul Walker, Jenny Khoo, Saye H. Taegtmeyer, Miriam Squire, S. Bertel Sloan, Derek J. Eur Respir J Agora The first successful use of bedaquiline for 18 months for XDR-TB as part of an optimised background regimen http://ow.ly/XE34x European Respiratory Society 2016-05 2016-02-25 /pmc/articles/PMC5394548/ /pubmed/26917618 http://dx.doi.org/10.1183/13993003.01980-2015 Text en Copyright ©ERS 2016 http://creativecommons.org/licenses/by-nc/4.0/ ERJ Open articles are open access and distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0.
spellingShingle Agora
Lewis, Joseph M.
Hine, Paul
Walker, Jenny
Khoo, Saye H.
Taegtmeyer, Miriam
Squire, S. Bertel
Sloan, Derek J.
First experience of effectiveness and safety of bedaquiline for 18 months within an optimised regimen for XDR-TB
title First experience of effectiveness and safety of bedaquiline for 18 months within an optimised regimen for XDR-TB
title_full First experience of effectiveness and safety of bedaquiline for 18 months within an optimised regimen for XDR-TB
title_fullStr First experience of effectiveness and safety of bedaquiline for 18 months within an optimised regimen for XDR-TB
title_full_unstemmed First experience of effectiveness and safety of bedaquiline for 18 months within an optimised regimen for XDR-TB
title_short First experience of effectiveness and safety of bedaquiline for 18 months within an optimised regimen for XDR-TB
title_sort first experience of effectiveness and safety of bedaquiline for 18 months within an optimised regimen for xdr-tb
topic Agora
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5394548/
https://www.ncbi.nlm.nih.gov/pubmed/26917618
http://dx.doi.org/10.1183/13993003.01980-2015
work_keys_str_mv AT lewisjosephm firstexperienceofeffectivenessandsafetyofbedaquilinefor18monthswithinanoptimisedregimenforxdrtb
AT hinepaul firstexperienceofeffectivenessandsafetyofbedaquilinefor18monthswithinanoptimisedregimenforxdrtb
AT walkerjenny firstexperienceofeffectivenessandsafetyofbedaquilinefor18monthswithinanoptimisedregimenforxdrtb
AT khoosayeh firstexperienceofeffectivenessandsafetyofbedaquilinefor18monthswithinanoptimisedregimenforxdrtb
AT taegtmeyermiriam firstexperienceofeffectivenessandsafetyofbedaquilinefor18monthswithinanoptimisedregimenforxdrtb
AT squiresbertel firstexperienceofeffectivenessandsafetyofbedaquilinefor18monthswithinanoptimisedregimenforxdrtb
AT sloanderekj firstexperienceofeffectivenessandsafetyofbedaquilinefor18monthswithinanoptimisedregimenforxdrtb